Literature DB >> 17278117

Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia.

Isabelle Steiner1, Christoph Aebi, Annette Ridolfi Lüthy, Bendicht Wagner, Kurt Leibundgut.   

Abstract

Disseminated adenoviral infection with hepatitis is rare in children undergoing standard chemotherapy. We report on a 3(1/2)-year-old male with fatal adenovirus hepatitis receiving maintenance chemotherapy for acute lymphoblastic leukemia (ALL). Adenoviral hepatitis was proven by histology, viral culture, and PCR in a liver biopsy. Quantitative real-time PCR in the peripheral blood showed adenoviral DNA copy number >10(9)/ml. Despite aggressive supportive care and antiviral treatment with cidofovir, the patient died rapidly due to fulminant liver failure. Diagnostic and treatment options for adenovirus infection remain unsatisfactory for these patients. We propose suggestions for diagnosis and therapy. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17278117     DOI: 10.1002/pbc.21120

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  16 in total

1.  Viral and Cellular Genomes Activate Distinct DNA Damage Responses.

Authors:  Govind A Shah; Clodagh C O'Shea
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

2.  Fiber shaft-chimeric adenovirus vectors lacking the KKTK motif efficiently infect liver cells in vivo.

Authors:  Nelson C Di Paolo; Oleksandr Kalyuzhniy; Dmitry M Shayakhmetov
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

Review 3.  Adenovirus infections in immunocompetent and immunocompromised patients.

Authors:  Thomas Lion
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 4.  Gastrointestinal and liver infections in children undergoing antineoplastic chemotherapy in the years 2000.

Authors:  Elio Castagnola; Eliana Ruberto; Alfredo Guarino
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

5.  Expression of an engineered soluble coxsackievirus and adenovirus receptor by a dimeric AAV9 vector inhibits adenovirus infection in mice.

Authors:  C Röger; T Pozzuto; R Klopfleisch; J Kurreck; S Pinkert; H Fechner
Journal:  Gene Ther       Date:  2015-03-19       Impact factor: 5.250

Review 6.  Fulminant hepatitis due to human adenovirus.

Authors:  B A Ronan; N Agrwal; E J Carey; G De Petris; S Kusne; M T Seville; J E Blair; H R Vikram
Journal:  Infection       Date:  2013-08-24       Impact factor: 3.553

7.  Exploring the association of hemoglobin level and adverse events in children with cancer presenting with fever in neutropenia.

Authors:  Roland A Ammann; Felix K Niggli; Kurt Leibundgut; Oliver Teuffel; Nicole Bodmer
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

8.  A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study.

Authors:  Philipp Agyeman; Udo Kontny; David Nadal; Kurt Leibundgut; Felix Niggli; Arne Simon; Andreas Kronenberg; Reno Frei; Hugo Escobar; Thomas Kühne; Maja Beck-Popovic; Nicole Bodmer; Roland A Ammann
Journal:  Pediatr Infect Dis J       Date:  2014-09       Impact factor: 2.129

Review 9.  The Role of Emerging and Neglected Viruses in the Etiology of Hepatitis.

Authors:  Anna Mrzljak; Irena Tabain; Hrvoje Premac; Maja Bogdanic; Ljubo Barbic; Vladimir Savic; Vladimir Stevanovic; Ana Jelic; Danko Mikulic; Tatjana Vilibic-Cavlek
Journal:  Curr Infect Dis Rep       Date:  2019-11-21       Impact factor: 3.663

Review 10.  Pediatric sepsis: important considerations for diagnosing and managing severe infections in infants, children, and adolescents.

Authors:  Adrienne G Randolph; Russell J McCulloh
Journal:  Virulence       Date:  2013-11-13       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.